RxDoctor Payments DataLook up a doctor →

Jerome Barakos, MD

Diagnostic Radiology · San Francisco, CANPI 1972558922

Payments from drug & device makers

$2,488,048in general payments, 2019–2025

Across 29 payments — averaging $85,795 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Providence Medical Technology, Inc.$2.4M
  • Eisai Inc.$53K
  • Biogen$39K
$1,883,123in research payments, 2019–2025

Across 55 payments — averaging $34,239 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$1.7M
  • E.r. Squibb & Sons, L.L.C.$211K
  • F. Hoffmann-la Roche AG$2K

General payments by program year

20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Providence Medical Technology, Inc.7$2,395,529
Eisai Inc.6$53,040
Biogen16$39,479

How this compares

$2,488,048 in reported general payments places this provider in the 95th percentile of 3,537 diagnostic radiology providers in California.

See all diagnostic radiology providers in California

Medicare billing

Part B allowed, 2024
$201,632
Medicare patients
3,214
Services billed
5,085

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other diagnostic radiology in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →